-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KwAeG1UpgaLV3pnhIhXN1HJIqvJL0SBOpq1KKe+ym02huZ31EHVyzvFeBOtjWLvm w93WFw5RI43wpXzMj347Ow== 0001209191-04-017652.txt : 20040326 0001209191-04-017652.hdr.sgml : 20040326 20040326122349 ACCESSION NUMBER: 0001209191-04-017652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040325 FILED AS OF DATE: 20040326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WORTZMAN MARILYN E CENTRAL INDEX KEY: 0001235962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 04691918 BUSINESS ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS INC STREET 2: 3031 RESEEARCH DRIVE BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 4 1 doc4.xml FORM 4 SUBMISSION X0201 4 2004-03-25 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235962 WORTZMAN MARILYN E C/O ONYX PHARMACEUTICALS, INC. 3031 RESEARCH DR., BLDG. A RICHMOND CA 94806 0 1 0 0 VP, Finance and Administration Common Stock 2004-03-25 4 M 0 1250.0000 4.0000 A 1736.0000 D Common Stock 2004-03-25 4 M 0 1393.0000 5.0000 A 3129.0000 D Common Stock 2004-03-25 4 S 0 2643.0000 37.5000 D 486.0000 D Stock Option (Right to Buy) 4.0000 2004-03-25 4 M 0 1250.0000 0 D 2003-01-22 2012-07-21 Common Stock 1250.0000 9062.0000 D Stock Option (Right to Buy) 5.0000 2004-03-25 4 M 0 1393.0000 0 D 2003-08-12 2013-02-12 Common Stock 1393.0000 23607.0000 D The options become exercisable at a rate of 12.5% 6 months from the date of grant and monthly thereafter /s/ Marilyn E. Wortzman 2004-03-26 -----END PRIVACY-ENHANCED MESSAGE-----